Synopsis
Spinal and bulbar muscular atrophy (SBMA), or Kennedy’s disease, is a slowly progressive X-linked neuromuscular disease caused by a trinucleotide (CAG) repeat expansion in the androgen receptor (AR) gene. Affected males typically develop weakness in their mid-forties, as well as evidence of androgen insensitivity with reduced fertility and gynecomastia. Diagnosis is often delayed because of decreased awareness of the disease, although genetic testing allows direct diagnosis of the disease. Therapeutic strategies to block the function of the mutant androgen receptor have been unsuccessful thus far, and evaluation of additional candidate therapies is underway.